Lonza Group (OTCMKTS:LZAGY) Trading Down 1.8% – What’s Next?

Lonza Group Ag (OTCMKTS:LZAGY)’s share price dropped 1.8% during mid-day trading on Tuesday . The company traded as low as $68.22 and last traded at $68.39. Approximately 110,827 shares changed hands during mid-day trading, an increase of 249% from the average daily volume of 31,733 shares. The stock had previously closed at $69.64.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered shares of Lonza Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 22nd. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Lonza Group currently has an average rating of “Hold”.

Lonza Group Price Performance

The company’s 50 day simple moving average is $67.69 and its 200 day simple moving average is $68.75. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.46 and a quick ratio of 0.87.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.